Gene Variants and Lung Cancer Risk
Author Information
Author(s): Ye Zheng, Song Honglin, Higgins Julian P. T, Pharoah Paul, Danesh John
Primary Institution: University of Cambridge
Hypothesis
Do variants in the GST detoxification genes affect the risk of lung cancer?
Conclusion
The risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism.
Supporting Evidence
- The meta-analysis included data from over 23,000 lung cancer patients and 30,000 controls.
- Overall, the relative risk for lung cancer associated with the GSTM1 null genotype was 1.22.
- Analysis of larger studies showed non-significant associations for GSTM1 and GSTT1 null genotypes.
- Ethnic background was a significant source of heterogeneity among studies.
Takeaway
Scientists looked at how certain gene changes might affect the chances of getting lung cancer, but they found that these changes don't seem to make a big difference.
Methodology
Literature-based meta-analysis of 130 studies involving genetic association studies of five GST polymorphisms.
Potential Biases
There is a possibility of publication bias, particularly for the GSTM1 null genotype.
Limitations
Data on some variants were sparse, making it difficult to assess their impact reliably, and the study lacked individual participant data for more detailed analyses.
Participant Demographics
48% of lung cancer cases were individuals of European continental ancestry, 37% East Asian, and 15% of other ethnic origins.
Statistical Information
Confidence Interval
95% CI: 1.14–1.23
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website